Oncology Institute Inc. CW-22STLNWPreferred / convertible
13F holders, Q2 2025 (June 30)11holders
1new positions
1sold out
$0.05avg. 13F price*
At the end of Q2 2025, 11 institutions reported holding Oncology Institute Inc. CW-22 (STLNW) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were LMR Partners LLP ($83K), Deerfield Management Company, L.P. ($64K) and Davidson Kempner Capital Management LP ($16K).
- Company
- Oncology Institute Inc. CW-22
- Filed as
- THE ONCOLOGY INSTITUTE INC (Q2 2025)
- CUSIP
- 68236X118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $10K |
| Exits | 1 | $501 |
All 13F filers, Q1 2025 → Q2 2025: 307,572 shares bought and 19,000 shares sold, net +288,572 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| LMR Partners LLP | — | No change | 1,624,856 | $83K |
| Deerfield Management Company, L.P. | — | No change | 1,250,000 | $64K |
| Davidson Kempner Capital Management LP | — | No change | 318,710 | $16K |
| Wolverine Asset Management LLC | — | Add +164.9% | 191,565 | $10K |
| Toronto Dominion Bank | — | New | 187,674 | $10K |
| Man Group plc | — | No change | 88,824 | $5K |
| Healthcare of Ontario Pension Plan Trust Fund | — | No change | 87,500 | $4K |
| Alpine Global Management, LLC | — | No change | 25,024 | $1K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 25,000 | $1K |
| Clear Street LLC | — | Reduce -7.5% | 6,128 | $314 |
| UBS Group AG | — | Add +21.5% | 3,670 | $187 |
"% of holder's portfolio" is STLNW's weight in each manager's 13F, not the share of Oncology Institute Inc. CW-22 the manager owns.